For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Abeona Therapeutics Inc (NASDAQ: ABEO) was $4.56 for the day, down -4.60% from the previous closing price of $4.78. In other words, the price has decreased by -$4.60 from its previous closing price. On the day, 0.88 million shares were traded. ABEO stock price reached its highest trading level at $5.065 during the session, while it also had its lowest trading level at $4.54.
Ratios:
Our analysis of ABEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.15 and its Current Ratio is at 4.15. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 18, 2020, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $5.
On February 10, 2020, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $6.SVB Leerink initiated its Outperform rating on February 10, 2020, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 26 ’24 when Charles Faith L. bought 7,550 shares for $3.28 per share. The transaction valued at 24,764 led to the insider holds 78,323 shares of the business.
Seshadri Vishwas bought 10,000 shares of ABEO for $32,000 on Apr 25 ’24. The Chief Executive Officer now owns 538,260 shares after completing the transaction at $3.20 per share. On Apr 25 ’24, another insider, O’Malley Brendan M., who serves as the SVP, General Counsel of the company, bought 8,600 shares for $3.24 each. As a result, the insider paid 27,864 and bolstered with 188,718 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABEO now has a Market Capitalization of 124738800 and an Enterprise Value of 77912968. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.65 while its Price-to-Book (P/B) ratio in mrq is 8.16. Its current Enterprise Value per Revenue stands at 22.261 whereas that against EBITDA is -1.697.
Stock Price History:
Over the past 52 weeks, ABEO has reached a high of $9.01, while it has fallen to a 52-week low of $2.83. The 50-Day Moving Average of the stock is -33.92%, while the 200-Day Moving Average is calculated to be -9.68%.
Shares Statistics:
ABEO traded an average of 672.09K shares per day over the past three months and 2147550 shares per day over the past ten days. A total of 26.52M shares are outstanding, with a floating share count of 25.88M. Insiders hold about 5.40% of the company’s shares, while institutions hold 52.21% stake in the company. Shares short for ABEO as of 1713139200 were 2061402 with a Short Ratio of 3.07, compared to 1710460800 on 1703738. Therefore, it implies a Short% of Shares Outstanding of 2061402 and a Short% of Float of 7.93.
